High HBV seroprotection rates in infants born to people with HIV and HBV infection in sub-Saharan Africa

There is little data on hepatitis B surface antibody (anti-HBs) responses in HIV-exposed, uninfected (HEU) infants born to people living with HIV and hepatitis B virus infection (HBV) (HEU-HBV). We examined anti-HBs titers in infants in a post-hoc analysis of the HIV Prevention Trials Network (HPTN) 046 trial. Thirty-three infants were tested for anti-HBs at 6 and 12 months. Of these, 84.8 % had a protective response (anti-HBs >10 IU/ml) at 6 months, and 97 % had anti-HBs >10 IU/ml at 12 months. Infants with low birth weight ([LBW] ≤2500 g) had lower median anti-HBs titers at 6 and 12 months (472 IU/mL and 48 IU/mL, respectively) compared to infants without LBW, although this was not statistically significant. Anti-HBs titers at 6 and 12 months in HEU-HBV are similar to those in HIV unexposed, uninfected (HUU) infants.

Authors

Institutions

Publication Details

Journal
Vaccine X
Published
2025-11-21
DOI
https://doi.org/10.1016/j.jvacx.2025.100759
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High HBV seroprotection rates in infants born to people with HIV and HBV infection in sub-Saharan Africa

Tsungai Chipato, Yvonne Maldonado, Rong Guo, Tian-hao Zhang et al.
Vaccine X
Hepatitis B Virus Studies
article

High HBV seroprotection rates in infants born to people with HIV and HBV infection in sub-Saharan Africa

Tsungai Chipato, Yvonne Maldonado, Rong Guo, Tian-hao Zhang, Chi‐Hong Tseng, Dhayendre Moodley, Kenneth Kintu, Lynda Stranix‐Chibanda, Karim Manji, Shih-Hsin Chiu, Chloe L. Thio, Neaka Mohtashemi, Lynda Emel, Hannah Ship, Mary Catherine Cambou, Judith S. Currier, Debika Bhattacharya, Julia Spaczai
article en

Abstract

There is little data on hepatitis B surface antibody (anti-HBs) responses in HIV-exposed, uninfected (HEU) infants born to people living with HIV and hepatitis B virus infection (HBV) (HEU-HBV). We examined anti-HBs titers in infants in a post-hoc analysis of the HIV Prevention Trials Network (HPTN) 046 trial. Thirty-three infants were tested for anti-HBs at 6 and 12 months. Of these, 84.8 % had a protective response (anti-HBs >10 IU/ml) at 6 months, and 97 % had anti-HBs >10 IU/ml at 12 months. Infants with low birth weight ([LBW] ≤2500 g) had lower median anti-HBs titers at 6 and 12 months (472 IU/mL and 48 IU/mL, respectively) compared to infants without LBW, although this was not statistically significant. Anti-HBs titers at 6 and 12 months in HEU-HBV are similar to those in HIV unexposed, uninfected (HUU) infants.

Vaccine XVol. 27
Johns Hopkins University (US), University of Zimbabwe (ZW), Muhimbili University of Health and Allied Sciences (TZ), University of California, Los Angeles (US), Johns Hopkins Medicine (US), Centre for the AIDS Programme of Research in South Africa (ZA), Fred Hutch Cancer Center (US), MUJHU Research Collaboration (UG), University of KwaZulu-Natal (ZA), Stanford University (US)
Openalex Percentile: Top 53%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.